LEADER 01732nam  2200529 a 450 
001 9910779626603321
005 20200520144314.0
010   $a1-61668-450-X
035   $a(CKB)2550000001042609
035   $a(EBL)3020440
035   $a(SSID)ssj0000883492
035   $a(PQKBManifestationID)12403608
035   $a(PQKBTitleCode)TC0000883492
035   $a(PQKBWorkID)10923522
035   $a(PQKB)11578367
035   $a(MiAaPQ)EBC3020440
035   $a(Au-PeEL)EBL3020440
035   $a(CaPaEBR)ebr10676730
035   $a(OCoLC)923663801
035   $a(EXLCZ)992550000001042609
100   $a20101001d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aMRSA (methicillin resistant Staphylococcus Aureus) infections and treatment$b[electronic resource] /$fManal M. Baddour
210   $aNew York $cNova Science Publishers$dc2010
215   $a1 online resource (140 p.)
225 1 $aPublic health in the 21st century series
300   $aDescription based upon print version of record.
311   $a1-61668-038-5 
320   $aIncludes bibliographical references (p. [83]-118) and index.
410  0$aPublic health in the 21st century series.
606   $aStaphylococcus aureus infections
606   $aMethicillin resistance
615  0$aStaphylococcus aureus infections.
615  0$aMethicillin resistance.
676   $a579.3/53
700   $aBaddour$b Manal M$01488404
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910779626603321
996   $aMRSA (methicillin resistant Staphylococcus Aureus) infections and treatment$93708649
997   $aUNINA